Literature DB >> 15708418

Atypical depression: a variant of bipolar II or a bridge between unipolar and bipolar II?

Hagop S Akiskal1, Franco Benazzi.   

Abstract

BACKGROUND: Although increasing data link atypical depression (AD) to the bipolar spectrum, controversies abound about the extent of the overlap. In particular, the Columbia group, which has pioneered in providing data on operational clarity and pharmacological specificity of atypical depressions, has nonetheless consistently avoided studying its discriminatory validity from bipolar II (BP-II). Accordingly, we undertook a full scale validation of such a link in a large clinical sample of BP-II and unipolar (UP) major depressive disorder (MDD).
METHODS: Consecutive 348 BP-II and 254 MDD outpatients presenting with major depressive episodes (MDE) were interviewed off psychoactive drugs with a modified Structured Clinical Interview for DSM-IV, the structured Family History Screen and the Hypomania Interview Guide. We used the DSM-IV criteria for "atypical features" specifier. Depressive mixed state was defined as > or =3 concurrent hypomanic signs and symptoms during MDE. Bipolar validators were age at onset, high depressive recurrence, depressive mixed state and bipolar family history (types I and II). Univariate and multivariate logistic regression were used to examine associations and control for confounding variables.
RESULTS: Frequency of AD was 43.0% in the combined BP-II and MDD sample. AD, versus non-AD, had significantly higher rates of BP-II. AD was significantly associated with all bipolar validators, among which family history was the most robust. A dose-response relationship was found between number of atypical symptoms during MDE and bipolar family history loading. The association between bipolar family history and number of atypical symptoms remained significant after controlling for the confounding effect of BP-II. Bipolar family history was strongly associated with the atypical symptoms of leaden paralysis and hypersomnia.
CONCLUSION: These results confirm a strong link between AD and bipolar validators along psychopathologic and familial grounds. From a practical standpoint, AD is best viewed as a variant of BP-II. Clinicians confronted with MDE patients presenting with atypical features should strongly consider a BP-II diagnosis. In a more hypothetical vein, atypicality-or some associated features thereof-might serve as a nosologic bridge between UP and BP-II.

Entities:  

Mesh:

Year:  2005        PMID: 15708418     DOI: 10.1016/j.jad.2004.05.004

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  37 in total

1.  Characteristics of depression among offspring at high and low familial risk of bipolar disorder.

Authors:  Rasim Somer Diler; Tina R Goldstein; Danella Hafeman; Brian Thomas Rooks; Dara Sakolsky; Benjamin I Goldstein; Kelly Monk; Mary Beth Hickey; David Axelson; Satish Iyengar; Boris Birmaher
Journal:  Bipolar Disord       Date:  2017-06-14       Impact factor: 6.744

2.  Efficacy and mood conversion rate of short-term fluoxetine monotherapy of bipolar II major depressive episode.

Authors:  Jay D Amsterdam; Justine Shults
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

3.  [Bipolar depression. Spectrum of clinical pictures and differentiation from unipolar depression].

Authors:  F Seemüller; M Riedel; S Dargel; N Djaja; R Schennach-Wolff; S Dittmann; H-J Möller; E Severus
Journal:  Nervenarzt       Date:  2010-05       Impact factor: 1.214

4.  Hypersomnia subtypes, sleep and relapse in bipolar disorder.

Authors:  K A Kaplan; E L McGlinchey; A Soehner; A Gershon; L S Talbot; P Eidelman; J Gruber; A G Harvey
Journal:  Psychol Med       Date:  2014-12-17       Impact factor: 7.723

5.  Hypersomnia in inter-episode bipolar disorder: does it have prognostic significance?

Authors:  Katherine A Kaplan; June Gruber; Polina Eidelman; Lisa S Talbot; Allison G Harvey
Journal:  J Affect Disord       Date:  2011-04-13       Impact factor: 4.839

6.  General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.

Authors:  Thomas C Baghai; Pierre Blier; David S Baldwin; Michael Bauer; Guy M Goodwin; Kostas N Fountoulakis; Siegfried Kasper; Brian E Leonard; Ulrik F Malt; Dan Stein; Marcio Versiani; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11       Impact factor: 5.270

7.  The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-12       Impact factor: 3.455

8.  Stability of symptoms across major depressive episodes in bipolar disorder.

Authors:  Roy H Perlis; Michael J Ostacher; Rudolf Uher; Andrew A Nierenberg; Francesco Casamassima; Christine Kansky; Joseph R Calabrese; Michael Thase; Gary S Sachs
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

9.  Comparison of clinical characteristics of bipolar and depressive disorders in Korean clinical sample of youth: a retrospective chart review.

Authors:  Seung-Hyun Shon; Yeonho Joo; Jangho Park; Eric A Youngstrom; Hyo-Won Kim
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-08-21       Impact factor: 4.785

10.  The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.

Authors:  Cristina Toni; Giulio Perugi; Franco Frare; Giuseppe Tusini; Konstantinos N Fountoulakis; Kareen K Akiskal; Hagop S Akiskal
Journal:  Ann Gen Psychiatry       Date:  2008-11-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.